Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 73.16
- Piotroski Score 3.00
- Grade N/A
- Symbol (NXL)
- Company Nexalin Technology, Inc.
- Price $3.74
- Changes Percentage (-4.1%)
- Change -$0.16
- Day Low $3.50
- Day High $3.90
- Year High $4.36
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/11/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.67
- Trailing P/E Ratio -1.07
- Forward P/E Ratio -1.07
- P/E Growth -1.07
- Net Income $-4,648,709
Income Statement
Quarterly
Annual
Latest News of NXL
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Is Nexalin Technology (NASDAQ:NXL) In A Good Position To Invest In Growth?
Nexalin Technology (NASDAQ:NXL) stock has surged by 941%, despite its negative cash flow. Shareholders need to assess the company's cash runway, which is around 14 months, and consider the impact of p...
By Yahoo! Finance | 1 week ago -
Calculating The Fair Value Of Nuix Limited (ASX:NXL)
The fair value estimate for Nuix Limited is 31% higher than the analyst price target. Using the Discounted Cash Flow (DCF) model, future cash flows are projected and discounted to present value....
By Yahoo! Finance | 2 weeks ago -
Nuix Limited (ASX:NXL) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Nuix's stock has surged by 79% in the past three months, but its financial indicators show inconsistencies. The Return on Equity (ROE) of 1.8% is below the industry average of 8.0%, indicating lower p...
By Yahoo! Finance | 1 month ago
